Optimizing site activation to accelerate clinical trials
Strategies for overcoming modern challenges in the biopharmaceutical industry
This white paper addresses the growing challenges in the biopharmaceutical industry related to site activation delays, which hinder timely patient enrollment and market entry for new therapies. It highlights the increasing complexity of clinical trials, site saturation, and slower site contracting processes as key factors contributing to prolonged activation periods.
To mitigate these issues, the authors propose several solutions:
- Optimizing site engagement with a single point of contact
- Leveraging advanced technologies like AI and machine learning
- Employing analytics for proactive risk management
Implementing these strategies has demonstrated significant improvements in cycle times and overall trial efficiency, ultimately accelerating the delivery of life-saving treatments.
